Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 19 November 2026
- Last conf. stmt
- 5 November 2025
Astellas Engineered Small Molecules U.K. Limited
- Incorporated
- 12 December 2012 (13 years)
- Previously known as
- Nanna Therapeutics Limited (until 3 April 2024)Bactevo Limited (until 14 August 2018)
- Industry
- Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- David Barrett
- Owned by
- Accounts type
- Full
- Region
- East of England
- Address
- Merrifield CentreRosemary LaneCambridgeCB1 3LQ
Officers 2 active
Officer details are public data from the Companies House register.
Barrett, David, Dr
Director · Appointed 24 August 2022
British
Born January 1962 (64)
Director · Appointed 18 April 2020
British
Born October 1967 (59)
Officer history (8 former)
24 August 2022
Resigned Shitaka, Yoshitsugu, Mr. as Director
24 August 2022
Appointed Barrett, David, Dr as Director
15 October 2021
13 September 2021
Appointed Shitaka, Yoshitsugu, Mr. as Director
31 March 2021
Resigned Iwai, Akihiko as Director
18 April 2020
18 April 2020
Appointed Iwai, Akihiko as Director
18 April 2020
18 April 2020
Resigned Thompson, Nicola, Dr as Director
17 June 2019
Appointed Thompson, Nicola, Dr as Director
8 February 2018
22 January 2018
24 December 2017
22 March 2013
22 March 2013
22 March 2013
12 December 2012
12 December 2012
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 18 April 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 02486792
Former controllers (1)
22 March 2018
Ceased New Wave Ventures LLP — Owns 50–75% of shares
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Astellas Engineered Small Molecules U.K. Limited This company Owns 75–100% of shares
Astellas Pharma Ltd. Owns 75–100% of shares
Financials
Figures from 2020 accounts. Newer accounts, made up to 31 March 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £312,158
- down £280,353 (47%)
- Cash
- £378,052
- down £277,480 (42%)
- Employees
- 14
- up 3 (27%)
- Debt Ratio
- 52%
- Current Ratio
- 1.5x
Balance sheet detail
| 2020 | |
|---|---|
| Fixed Assets | £139,687 |
| Current Assets | £511,418 |
| Debtors | £133,366 |
| Cash | £378,052 |
| Creditors (< 1 year) | £338,947 |
| Creditors (> 1 year) | £0 |
| Net Current Assets | £172,471 |
| Net Assets | £312,158 |
| Shareholder Funds | £312,158 |
Filings 94
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 January 2026 | Replacement filing for the appointment of a director | |||
| 28 January 2026 | Confirmation statement with updates | 5 November 2025 | ||
| 9 October 2025 | Full accounts | 31 March 2025 | ||
| 28 January 2025 | Statement of capital following an allotment of shares | |||
| 30 December 2024 | Full accounts | 31 March 2024 |
Other companies in this industry
London
Manchester
Beckenham
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →